Search by Drug Name or NDC
NDC 71288-0714-96 Cisatracurium Besylate 20 mg/10mL Details
Cisatracurium Besylate 20 mg/10mL
Cisatracurium Besylate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is CISATRACURIUM BESYLATE.
Product Information
| NDC | 71288-0714 |
|---|---|
| Product ID | 71288-714_d3c597b7-517b-4d79-9fdd-fa88f920111a |
| Associated GPIs | 74200013102016 |
| GCN Sequence Number | 024614 |
| GCN Sequence Number Description | cisatracurium besylate VIAL 2 MG/ML INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 32771 |
| HICL Sequence Number | 010278 |
| HICL Sequence Number Description | CISATRACURIUM BESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Cisatracurium Besylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cisatracurium Besylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/10mL |
| Substance Name | CISATRACURIUM BESYLATE |
| Labeler Name | Meitheal Pharmaceuticals Inc. |
| Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211669 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71288-0714-96 (71288071496)
| NDC Package Code | 71288-714-96 |
|---|---|
| Billing NDC | 71288071496 |
| Package | 10 VIAL, MULTI-DOSE in 1 CARTON (71288-714-96) / 10 mL in 1 VIAL, MULTI-DOSE (71288-714-95) |
| Marketing Start Date | 2019-10-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |